InvestorsHub Logo
Followers 15
Posts 1122
Boards Moderated 0
Alias Born 07/28/2014

Re: finesand post# 1819

Sunday, 07/22/2018 7:11:40 PM

Sunday, July 22, 2018 7:11:40 PM

Post# of 3061
I don't see the company moving forward with P3 until partnership or the approval of the shares and R/S. We should already be in P3! Plain and simple, they don't have the funds. Too much time has gone by for a good (IOI) not to have been presented to the board. Why they haven't moved forward with the non-dilutive partnership route just baffles me. Is Anja and the board looking to go forward without partnership and fund P3 through offerings? Has greed set in? Are they waiting for a release of information that could start moving the share price higher? I know Anja stated that they were working on new undisclosed products. Are those the delay?

Everything is coming down to the wire. Many emails from BioPharmX have stated that there will be an announcement before the end of this quarter in regards to partnership/funding P3. Many longs are watching with concerned eyes.

Why are we in the twenties? Investors want to know how we're funding the next phase Anja! Pick an IOI!! Lock in a deal that's best for shareholders!

https://www.axial.net/forum/what-expect-indication-interest/

From a buyer's prospective
http://jimsteinsharpe.com/searching/making-the-offer/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.